A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)

The neuromuscular junction (NMJ) is the site where the motor neuron innervates skeletal muscle, enabling muscular contraction. Congenital myasthenic syndromes (CMS) arise when mutations in any of the approximately 35 known causative genes cause impaired neuromuscular transmission at the NMJ, resulti...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen Henry Holland, Ricardo Carmona-Martinez, Kaela O’Connor, Daniel O’Neil, Andreas Roos, Sally Spendiff, Hanns Lochmüller
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/10/1252
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850204903407878144
author Stephen Henry Holland
Ricardo Carmona-Martinez
Kaela O’Connor
Daniel O’Neil
Andreas Roos
Sally Spendiff
Hanns Lochmüller
author_facet Stephen Henry Holland
Ricardo Carmona-Martinez
Kaela O’Connor
Daniel O’Neil
Andreas Roos
Sally Spendiff
Hanns Lochmüller
author_sort Stephen Henry Holland
collection DOAJ
description The neuromuscular junction (NMJ) is the site where the motor neuron innervates skeletal muscle, enabling muscular contraction. Congenital myasthenic syndromes (CMS) arise when mutations in any of the approximately 35 known causative genes cause impaired neuromuscular transmission at the NMJ, resulting in fatigable muscle weakness. A subset of five of these CMS-causative genes are associated with protein glycosylation. Glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) is the rate-limiting enzyme within the hexosamine biosynthetic pathway (HBP), a metabolic pathway that produces the precursors for glycosylation. We hypothesized that deficiency in Gfpt1 expression results in aberrant or reduced glycosylation, impairing the proper assembly and stability of key NMJ-associated proteins. Using both in vitro and in vivo Gfpt1-deficient models, we determined that the acetylcholine receptor delta subunit (AChRδ) has reduced expression and is hypo-glycosylated. Using laser capture microdissection, NMJs were harvested from Gfpt1 knockout mouse muscle. A lower-molecular-weight species of AChRδ was identified at the NMJ that was not detected in controls. Furthermore, Gfpt1-deficient muscle lysates showed impairment in protein O-GlcNAcylation and sialylation, suggesting that multiple glycan chains are impacted. Other key NMJ-associated proteins, in addition to AChRδ, may also be differentially glycosylated in Gfpt1-deficient muscle.
format Article
id doaj-art-e5f54fce7e5a4e9f9e07f148b2265675
institution OA Journals
issn 2218-273X
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-e5f54fce7e5a4e9f9e07f148b22656752025-08-20T02:11:12ZengMDPI AGBiomolecules2218-273X2024-10-011410125210.3390/biom14101252A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)Stephen Henry Holland0Ricardo Carmona-Martinez1Kaela O’Connor2Daniel O’Neil3Andreas Roos4Sally Spendiff5Hanns Lochmüller6Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, CanadaChildren’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, CanadaChildren’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, CanadaChildren’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, CanadaDr. Eric Poulin Center for Neuromuscular Disorders, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON K1N 6N5, CanadaChildren’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, CanadaChildren’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, CanadaThe neuromuscular junction (NMJ) is the site where the motor neuron innervates skeletal muscle, enabling muscular contraction. Congenital myasthenic syndromes (CMS) arise when mutations in any of the approximately 35 known causative genes cause impaired neuromuscular transmission at the NMJ, resulting in fatigable muscle weakness. A subset of five of these CMS-causative genes are associated with protein glycosylation. Glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) is the rate-limiting enzyme within the hexosamine biosynthetic pathway (HBP), a metabolic pathway that produces the precursors for glycosylation. We hypothesized that deficiency in Gfpt1 expression results in aberrant or reduced glycosylation, impairing the proper assembly and stability of key NMJ-associated proteins. Using both in vitro and in vivo Gfpt1-deficient models, we determined that the acetylcholine receptor delta subunit (AChRδ) has reduced expression and is hypo-glycosylated. Using laser capture microdissection, NMJs were harvested from Gfpt1 knockout mouse muscle. A lower-molecular-weight species of AChRδ was identified at the NMJ that was not detected in controls. Furthermore, Gfpt1-deficient muscle lysates showed impairment in protein O-GlcNAcylation and sialylation, suggesting that multiple glycan chains are impacted. Other key NMJ-associated proteins, in addition to AChRδ, may also be differentially glycosylated in Gfpt1-deficient muscle.https://www.mdpi.com/2218-273X/14/10/1252glutamine-fructose-6-phosphate transaminase 1 (Gfpt1)congenital myasthenic syndrome (CMS)neuromuscular junction (NMJ)O-GlcNAcylationacetylcholine receptor delta subunit (AChRδ)glycosylation
spellingShingle Stephen Henry Holland
Ricardo Carmona-Martinez
Kaela O’Connor
Daniel O’Neil
Andreas Roos
Sally Spendiff
Hanns Lochmüller
A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
Biomolecules
glutamine-fructose-6-phosphate transaminase 1 (Gfpt1)
congenital myasthenic syndrome (CMS)
neuromuscular junction (NMJ)
O-GlcNAcylation
acetylcholine receptor delta subunit (AChRδ)
glycosylation
title A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
title_full A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
title_fullStr A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
title_full_unstemmed A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
title_short A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)
title_sort deficiency in glutamine fructose 6 phosphate transaminase 1 gfpt1 in skeletal muscle results in reduced glycosylation of the delta subunit of the nicotinic acetylcholine receptor achrδ
topic glutamine-fructose-6-phosphate transaminase 1 (Gfpt1)
congenital myasthenic syndrome (CMS)
neuromuscular junction (NMJ)
O-GlcNAcylation
acetylcholine receptor delta subunit (AChRδ)
glycosylation
url https://www.mdpi.com/2218-273X/14/10/1252
work_keys_str_mv AT stephenhenryholland adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT ricardocarmonamartinez adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT kaelaoconnor adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT danieloneil adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT andreasroos adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT sallyspendiff adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT hannslochmuller adeficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT stephenhenryholland deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT ricardocarmonamartinez deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT kaelaoconnor deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT danieloneil deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT andreasroos deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT sallyspendiff deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd
AT hannslochmuller deficiencyinglutaminefructose6phosphatetransaminase1gfpt1inskeletalmuscleresultsinreducedglycosylationofthedeltasubunitofthenicotinicacetylcholinereceptorachrd